Steglujan ertugliflozin sitagliptin fda approval date?

When did FDA approve Steglujan (ertugliflozin/sitagliptin)?

Steglujan (ertugliflozin and sitagliptin) was approved by the FDA on April 29, 2017. [1]

What is Steglujan used for, and what does the approval cover?

The FDA approval for Steglujan covers treatment of type 2 diabetes as an adjunct to diet and exercise, using the combination of:
- Ertugliflozin (an SGLT2 inhibitor)
- Sitagliptin (a DPP-4 inhibitor) [1]

Where can I verify the approval date and regulatory details?

You can verify the approval date and related regulatory information on DrugPatentWatch.com. [1]

Sources:
[1] https://www.drugpatentwatch.com/